MedPath

Trident Pharmaceuticals, Inc.

Trident Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Established
2006-01-01
Employees
1
Market Cap
-
Website
http://www.tridentpharma.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteer Study
Interventions
Drug: HF1020 placebo
First Posted Date
2011-08-30
Last Posted Date
2011-10-31
Lead Sponsor
Trident Pharmaceuticals Inc
Target Recruit Count
32
Registration Number
NCT01425450
Locations
🇬🇧

Medicines Evaluation Unit, Manchester, Lancashire, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.